CVS Health beats expectations as turnaround strategy gains traction
CVS Health delivered a stronger-than-expected fourth quarter, beating Wall Street estimates on both earnings and revenue as the company presses ahead with a
Gold
Gold
Workday stock is stuck in a bear market: is it a bargain in plain sight?
Workday stock price has slipped into a technical bear market, moving from a record high of $310 in 2024 to the current $155.
Gold
PUMP could dip below $0.0019 amid low retail interest: check forecast
Pump.fun (PUMP) has lost 4% of its value on Tuesday as the broader cryptocurrency market has underperformed since the start of the week.
Gold
Brazil reviews US-Argentina trade deal for possible Mercosur breach: report
Brazil is reviewing a trade deal announced between the United States and Argentina last week, citing suspicions that the agreement would violate South American
Gold
US stocks open higher on Tuesday: Dow Jones jumps 200 points to hit new ATH
US stocks moved higher on Tuesday, with the Dow Jones Industrial Average setting another all-time high, as investors digested weaker-than-expected retail sales data
Oil
HYPE sheds 18% in one week: will it retest the $27 support level?
HYPE, the native coin of the Hyperliquid DEX, has lost 18% of its value since hitting its yearly high of $38 last week.
Oil
Coca-Cola stock slumps as Q4 revenue misses estimates
Coca-Cola shares fell on Tuesday after the beverage giant reported quarterly revenue growth that came in below analysts’ expectations, overshadowing a modest earnings
Oil
Jupiter price slides below $0.15 amid technical breakdown
Jupiter (JUP), the governance token for the leading Solana-based decentralized exchange aggregator, has dropped to below $0.15 as it continues its downward spiral.
Oil
Workday stock is stuck in a bear market: is it a bargain in plain sight?
Workday stock price has slipped into a technical bear market, moving from a record high of $310 in 2024 to the current $155.
Oil
CVS Health beats expectations as turnaround strategy gains traction
CVS Health delivered a stronger-than-expected fourth quarter, beating Wall Street estimates on both earnings and revenue as the company presses ahead with a